Product image of Entyvio (Vedolizumab) supplied by GNH India

Entyvio

Active Ingredient:
Vedolizumab
Origin:
EU

Entyvio (Vedolizumab)

Entyvio (Vedolizumab) is a subcutaneous medication used to manage inflammatory conditions. Learn about its uses, effects, and precautions for safe administration.

Manufacturer / TM Owner

Takeda Pharma A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Entyvio (Vedolizumab) is primarily used for the treatment of inflammatory conditions. It is often prescribed for managing symptoms related to gastrointestinal inflammation. Patients may wonder, 'What is Entyvio used for?' and the answer lies in its ability to target specific inflammatory pathways, providing relief for those suffering from chronic inflammatory disorders.

Side Effects

  • Common effects of Entyvio (Vedolizumab) may include reactions at the injection site, such as redness or swelling. Some users might experience general discomfort or fatigue. These effects are typically mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

  • Entyvio (Vedolizumab) should be handled with care. It is important to follow the prescribed administration guidelines to minimize the risk of infection or other complications. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment.

Avoid Interactions

  • Entyvio (Vedolizumab) may interact with other medications, including those that suppress the immune system. It is advisable to avoid alcohol and consult a healthcare provider before taking any new medications. Always inform your healthcare provider about all the medications you are currently taking to avoid potential interactions.

Frequently Asked Questions

Entyvio (Vedolizumab) is used to manage inflammatory conditions, particularly those affecting the gastrointestinal tract.

Entyvio (Vedolizumab) is administered subcutaneously, meaning it is injected under the skin.

Common side effects may include reactions at the injection site, such as redness or swelling, and general discomfort or fatigue.

Entyvio (Vedolizumab) may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

The safety of long-term use of Entyvio (Vedolizumab) should be discussed with a healthcare provider, who can assess individual health conditions and risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Vedolizumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT